EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

De Novo Expressed Vpr Stimulates HIV-1 Replication in T Cells

Blessing Enya iD, Jacek Skowronski iD

Viruses · 2025

DOI: 10.3390/v17070958 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2025. Verfasst von Blessing Enya und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Biology and Microbiology, Case Western Reserve School of Medicine, 10900 Euclid Ave., Cleveland, OH 44106, USA. Hauptthemen laut MEDLINE: Virus Replication, HIV-1, vpr Gene Products, Human Immunodeficiency Virus, T-Lymphocytes. Die Arbeit nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAID NIH HHS, NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Vpr, a virion-associated accessory virulence factor of HIV-1, promotes virus replication in both T cells and macrophages. Although Vpr’s early activity—antagonism of preintegration silencing and host restriction factors—has been documented, the relative contribution of virion-associated versus de novo expressed Vpr to HIV-1 replication fitness remains unclear. Here, we developed a T cell-based system that genetically separates early and late Vpr functions by combining tetracycline-inducible Vpr expression in CEM.SS T cells with vpr-deficient HIV-1 constructs and Gag p6 mutations that block Vpr packaging. CEM.SS T cells have been shown to recapitulate the positive effect of Vpr on HIV-1 replication observed in activated primary T cells. Using pairwise replication fitness assays under spreading infection conditions, we demonstrate that de novo synthesized Vpr exerts the dominant effect on HIV-1 replication in T cells, while virion-associated Vpr plays a lesser role. Somewhat unexpectedly, our findings reveal that antagonism of preintegration HIV-1 silencing by virion-associated Vpr is unlikely to be the major driver of enhanced HIV-1 replication in proliferating T cells. Instead, this function may play a more prominent role in the infection of non-dividing T cells and/or other cell types.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Virus ReplicationHIV-1vpr Gene Products, Human Immunodeficiency VirusT-LymphocytesHumansVirionHIV InfectionsCell Line

Stichwörter der Autor:innen

HIV-1 VprT cellsaccessory proteinspreintegration silencingretroviral pathogenesisviral replicationvirion-associated Vpr

Substanzen

vpr Gene Products, Human Immunodeficiency Virusvpr protein, Human immunodeficiency virus 1

Autor:innen und Institutionen

  • Department of Molecular Biology and Microbiology, Case Western Reserve School of Medicine, 10900 Euclid Ave., Cleveland, OH 44106, USA.

ORCID-Profile: Blessing Enya, Jacek Skowronski

Förderung

  • NIH HHS
  • NIAID NIH HHS
  • NIGMS NIH HHS
  • National Institute for Alergy and Infectious Diseases
  • National Institute for General Medical Sciences
  • CWRU funds

Zitieren

APA

Enya, B., & Skowronski, J. (2025). De Novo Expressed Vpr Stimulates HIV-1 Replication in T Cells. Viruses. https://doi.org/10.3390/v17070958

Vancouver

Enya B, Skowronski J. De Novo Expressed Vpr Stimulates HIV-1 Replication in T Cells. Viruses. 2025. doi:10.3390/v17070958

BibTeX
@article{Enya2025,
  author = {Enya, Blessing and Skowronski, Jacek},
  title = {De Novo Expressed Vpr Stimulates HIV-1 Replication in T Cells},
  journal = {Viruses},
  year = {2025},
  doi = {10.3390/v17070958}
}
Kostenlos starten →